-
2
-
-
0014951460
-
The switch process from depression to mania: Relationship to drugs which alter brain amines
-
Bunney WE Jr, Murphy DL, Goodwin FK, et al: The switch process from depression to mania: relationship to drugs which alter brain amines. Lancet 1970; 1:1022-1027
-
(1970)
Lancet
, vol.1
, pp. 1022-1027
-
-
Bunney Jr., W.E.1
Murphy, D.L.2
Goodwin, F.K.3
-
3
-
-
0029953520
-
Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression
-
Sonntag A, Rothe B, Guldner J, et al: Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. Depression 1996; 4:1-13
-
(1996)
Depression
, vol.4
, pp. 1-13
-
-
Sonntag, A.1
Rothe, B.2
Guldner, J.3
-
5
-
-
4444260616
-
The therapeutic role of 5-HT1A and 5-HT2A receptors in depression
-
Celada P, Puig M, Amargós-Bosch M, et al: The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 2004; 29:252-265
-
(2004)
J Psychiatry Neurosci
, vol.29
, pp. 252-265
-
-
Celada, P.1
Puig, M.2
Amargós-Bosch, M.3
-
6
-
-
0037212076
-
Place of chronic insomnia in the course of depressive and anxiety disorders
-
Ohayon MM, Roth T: Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 2003; 37:9-15
-
(2003)
J Psychiatr Res
, vol.37
, pp. 9-15
-
-
Ohayon, M.M.1
Roth, T.2
-
7
-
-
0028105342
-
Sleep disorders and melatonin rhythms in elderly people
-
Haimov I, Laudon M, Zisapel N, et al: Sleep disorders and melatonin rhythms in elderly people. BMJ 1994; 309:167
-
(1994)
BMJ
, vol.309
, pp. 167
-
-
Haimov, I.1
Laudon, M.2
Zisapel, N.3
-
8
-
-
0032434461
-
Altered circadian melatonin secretion patterns in relation to sleep in patients with chronic sleep-wake rhythm disorders
-
Rodenbeck A, Huether G, Rüther E, et al: Altered circadian melatonin secretion patterns in relation to sleep in patients with chronic sleep-wake rhythm disorders. J Pineal Res 1998; 25:201-210
-
(1998)
J Pineal Res
, vol.25
, pp. 201-210
-
-
Rodenbeck, A.1
Huether, G.2
Rüther, E.3
-
9
-
-
0346727185
-
Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy
-
LegerD, LaudonM, Zisapel N:Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. Am J Med 2004; 116:91-95
-
(2004)
Am J Med
, vol.116
, pp. 91-95
-
-
Leger, D.1
Laudon, M.2
Zisapel, N.3
-
10
-
-
0031870926
-
Melatonin for the treatment of sleep disturbances in major depressive disorder
-
Dolberg OT, Hirschmann S, Grunhaus L: Melatonin for the treatment of sleep disturbances in major depressive disorder. Am J Psychiatry 1998; 155:1119-1121
-
(1998)
Am J Psychiatry
, vol.155
, pp. 1119-1121
-
-
Dolberg, O.T.1
Hirschmann, S.2
Grunhaus, L.3
-
11
-
-
0041932292
-
The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine 2c receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways
-
Millan MJ, Gobert A, Lejeune E, et al: The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine 2c receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. Pharmacol Exp Ther 2003; 306:954-964
-
(2003)
Pharmacol Exp Ther
, vol.306
, pp. 954-964
-
-
Millan, M.J.1
Gobert, A.2
Lejeune, E.3
-
13
-
-
70349570733
-
Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: A 24-week randomized, doubleblind, placebo-controlled trial
-
Agomelatine Study Group
-
Goodwin GM, Emsley R, Rembry S, et al; Agomelatine Study Group: Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, doubleblind, placebo-controlled trial. J Clin Psychiatry 2009; 70:1128-1137
-
(2009)
J Clin Psychiatry
, vol.70
, pp. 1128-1137
-
-
Goodwin, G.M.1
Emsley, R.2
Rembry, S.3
-
14
-
-
0036738228
-
D' haenen H: Determination of the dose of agomelatine, a melatonergic agonist and selective 5-HT (2C) antagonist, in the treatment of major depressive disorder: A placebo-controlled dose range study
-
Loo H, Hale A: D' haenen H: Determination of the dose of agomelatine, a melatonergic agonist and selective 5-HT (2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. Psychopharmacology (Berl) 2002; 17:239-247
-
(2002)
Psychopharmacology (Berl)
, vol.17
, pp. 239-247
-
-
Loo, H.1
Hale, A.2
-
15
-
-
31344471423
-
Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
-
Kennedy SH, Emsley R: Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. Eur Neuropsychopharmacol 2006; 16:93-100
-
(2006)
Eur Neuropsychopharmacol
, vol.16
, pp. 93-100
-
-
Kennedy, S.H.1
Emsley, R.2
-
18
-
-
0015173259
-
Melatonin metabolism: Neural regulation of pineal serotonin: Acetyl coenzyme A Nacetyltransferase activity
-
Klein DC, Weller JL, Moore RY: Melatonin metabolism: neural regulation of pineal serotonin: acetyl coenzyme A Nacetyltransferase activity. Proc Natl Acad Sci USA 1971; 68:3107-3110
-
(1971)
Proc Natl Acad Sci USA
, vol.68
, pp. 3107-3110
-
-
Klein, D.C.1
Weller, J.L.2
Moore, R.Y.3
-
19
-
-
0015124725
-
Metabolism of serotonin by the rat retina in vitro
-
Cardinali DP, Rosner JM: Metabolism of serotonin by the rat retina in vitro. J Neurochem 1971; 18:1769-1770
-
(1971)
J Neurochem
, vol.18
, pp. 1769-1770
-
-
Cardinali, D.P.1
Rosner, J.M.2
-
20
-
-
0036798932
-
Gastrointestinal melatonin: Localization, function, and clinical relevance
-
Bubenik GA: Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002; 47:2336-2348
-
(2002)
Dig Dis Sci
, vol.47
, pp. 2336-2348
-
-
Bubenik, G.A.1
-
21
-
-
27644587826
-
On the role of melatonin in skin physiology and pathology
-
Slominski A, Fischer TW, Zmijewski MA, et al: On the role of melatonin in skin physiology and pathology. Endocrine 2005; 27:137-148
-
(2005)
Endocrine
, vol.27
, pp. 137-148
-
-
Slominski, A.1
Fischer, T.W.2
Zmijewski, M.A.3
-
22
-
-
2442648067
-
Evidence of melatonin synthesis by human lymphocytes and its physiological significance: Possible role as intracrine, autocrine, and/or paracrine substance
-
Carrillo-Vico A, Calvo JR, Abreu P, et al: Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J 2004; 18:537-539
-
(2004)
FASEB J
, vol.18
, pp. 537-539
-
-
Carrillo-Vico, A.1
Calvo, J.R.2
Abreu, P.3
-
23
-
-
33947493911
-
Melatonin biosynthesis in the thymus of humans and rats
-
Naranjo MC, Guerrero JM, Rubio A, et al: Melatonin biosynthesis in the thymus of humans and rats. Cell Mol Life Sci 2007; 64:781-790
-
(2007)
Cell Mol Life Sci
, vol.64
, pp. 781-790
-
-
Naranjo, M.C.1
Guerrero, J.M.2
Rubio, A.3
-
24
-
-
0642277241
-
Origin of cerebrospinal fluid melatonin and possible function in the integration of photoperiod
-
Tricoire H, Møller M, Chemineau P, et al: Origin of cerebrospinal fluid melatonin and possible function in the integration of photoperiod. Reprod Suppl 2003; 61:311-321
-
(2003)
Reprod Suppl
, vol.61
, pp. 311-321
-
-
Tricoire, H.1
Møller, M.2
Chemineau, P.3
-
25
-
-
11844277100
-
The basic physiology and pathophysiology of melatonin
-
Claustrat B, Brun J, Chazot G: The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005; 9:11-24
-
(2005)
Sleep Med Rev
, vol.9
, pp. 11-24
-
-
Claustrat, B.1
Brun, J.2
Chazot, G.3
-
26
-
-
0015944572
-
In-vitro and in-vivo formation of two new metabolites of melatonin
-
Hirata F, Hayaishi O, Tokuyama T, et al: In-vitro and in-vivo formation of two new metabolites of melatonin. J Biol Chem 1974; 249:1311-1313
-
(1974)
J Biol Chem
, vol.249
, pp. 1311-1313
-
-
Hirata, F.1
Hayaishi, O.2
Tokuyama, T.3
-
27
-
-
0028018966
-
Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses
-
Reppert SM, Weaver DR, Ebisawa T: Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994; 13:1177-1185
-
(1994)
Neuron
, vol.13
, pp. 1177-1185
-
-
Reppert, S.M.1
Weaver, D.R.2
Ebisawa, T.3
-
28
-
-
0029115639
-
Molecular characterization of a second melatonin receptor expressed in human retina and brain: The Mel1b melatonin receptor
-
Reppert SM, Godson C, Mahle CD, et al: Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA 1995; 92:8734-8738
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 8734-8738
-
-
Reppert, S.M.1
Godson, C.2
Mahle, C.D.3
-
29
-
-
0033346394
-
Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins
-
Brydon L, Roka F, Petit L, et al: Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins. Mol Endocrinol 1999; 13:2025-2038
-
(1999)
Mol Endocrinol
, vol.13
, pp. 2025-2038
-
-
Brydon, L.1
Roka, F.2
Petit, L.3
-
30
-
-
22844439551
-
Molecular tools to study melatonin pathways and actions
-
Boutin JA, Audinot V, Ferry G, et al: Molecular tools to study melatonin pathways and actions. Trends Pharmacol Sci 2005; 26:412-419
-
(2005)
Trends Pharmacol Sci
, vol.26
, pp. 412-419
-
-
Boutin, J.A.1
Audinot, V.2
Ferry, G.3
-
31
-
-
65649123794
-
Melatonin and melatonergic drugs on sleep: Possible mechanisms of action
-
Srinivasan V, Pandi-Perumal SR, Trahkt I, et al: Melatonin and melatonergic drugs on sleep: possible mechanisms of action. Int J Neurosci 2009; 119:821-846
-
(2009)
Int J Neurosci
, vol.119
, pp. 821-846
-
-
Srinivasan, V.1
Pandi-Perumal, S.R.2
Trahkt, I.3
-
32
-
-
0019429224
-
Sleep and treatment prediction in endogenous depression
-
Kupfer DJ, Spiker DG, Coble PA, et al: Sleep and treatment prediction in endogenous depression. Am J Psychiatry 1981; 138:429-434
-
(1981)
Am J Psychiatry
, vol.138
, pp. 429-434
-
-
Kupfer, D.J.1
Spiker, D.G.2
Coble, P.A.3
-
33
-
-
0034944551
-
Sleep and depression: A challenge for anti-depresaants, an overview
-
Riemann D, Berger M, Voderholzer U: Sleep and depression: a challenge for anti-depresaants, an overview. Biol Psychol 2001; 57:67-103
-
(2001)
Biol Psychol
, vol.57
, pp. 67-103
-
-
Riemann, D.1
Berger, M.2
Voderholzer, U.3
-
34
-
-
33846329106
-
Sleep and circadian rhythms in mood disorders
-
Armitage R: Sleep and circadian rhythms in mood disorders. Acta Psychiatr Scand Suppl 2007; (433):104-115
-
(2007)
Acta Psychiatr Scand Suppl
, Issue.433
, pp. 104-115
-
-
Armitage, R.1
-
35
-
-
0024448838
-
Epidemiologic study of sleep disturbances and psychiatric disorders
-
Ford DE, Kamerow DB: Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989; 262:1479-1484
-
(1989)
An opportunity for prevention? JAMA
, vol.262
, pp. 1479-1484
-
-
Ford, D.E.1
Kamerow, D.B.2
-
36
-
-
33646689322
-
Sleep disturbances and depression: A challenge for antidepressants
-
Lam RW: Sleep disturbances and depression: a challenge for antidepressants. Int Clin Psychopharmacol 2006; 21(Suppl 1): S25-S29
-
(2006)
Int Clin Psychopharmacol
, vol.21
, Issue.SUPPL. 1
-
-
Lam, R.W.1
-
37
-
-
0034095861
-
Depression and insomnia: Questions of cause and effect
-
Lustberg L, Reynolds CF: Depression and insomnia: questions of cause and effect. Sleep Med Rev 2000; 4:253-262
-
(2000)
Sleep Med Rev
, vol.4
, pp. 253-262
-
-
Lustberg, L.1
Reynolds, C.F.2
-
38
-
-
67650594924
-
Bidirectional communication between sleep and circadian rhythms and its implications for depression: Lessons from agomelatine
-
Pandi-Perumal SR, Moscovitch A, Srinivasan V, et al: Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine. Prog Neurobiol 2009; 88:264-271
-
(2009)
Prog Neurobiol
, vol.88
, pp. 264-271
-
-
Pandi-Perumal, S.R.1
Moscovitch, A.2
Srinivasan, V.3
-
39
-
-
84859700294
-
Sleep, mood disorders and antidepressants: Themelatonergic anti-depressant agomelatine offers a new strategy of treatment
-
Srinivasan V, Brzezinski A, Spence DW, et al: Sleep, mood disorders and antidepressants: themelatonergic anti-depressant agomelatine offers a new strategy of treatment. Psychiatr Fenn 2010; 41:168-187
-
(2010)
Psychiatr Fenn
, vol.41
, pp. 168-187
-
-
Srinivasan, V.1
Brzezinski, A.2
Spence, D.W.3
-
40
-
-
33749527675
-
Depression and associated sleep disturbances: Patient's benefits with agomelatine
-
Kupfer DJ: Depression and associated sleep disturbances: patient's benefits with agomelatine. Eur Neuropsychopharmacol 2006; 16(suppl5): S 639-S643
-
(2006)
Eur Neuropsychopharmacol
, vol.16
, Issue.SUPPL.5
-
-
Kupfer, D.J.1
-
41
-
-
33845909859
-
Pharmacotherapy of bipolar depression: An update
-
Thase ME: Pharmacotherapy of bipolar depression: an update. Curr Psychiatry Rep 2006; 8:478-488
-
(2006)
Curr Psychiatry Rep
, vol.8
, pp. 478-488
-
-
Thase, M.E.1
-
42
-
-
33947653784
-
Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies
-
Ruhé HG, Mason NS, Schene AH: Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 2007; 12:331-359
-
(2007)
Mol Psychiatry
, vol.12
, pp. 331-359
-
-
Ruhé, H.G.1
Mason, N.S.2
Schene, A.H.3
-
43
-
-
33646686569
-
Efficacy and tolerance profile of agomelatine and practical use in depressed patients
-
Rouillon F: Efficacy and tolerance profile of agomelatine and practical use in depressed patients. Int Clin Psychopharmacol 2006; 21(Suppl 1):S31-S35
-
(2006)
Int Clin Psychopharmacol
, vol.21
, Issue.SUPPL. 1
-
-
Rouillon, F.1
-
44
-
-
0026628711
-
Novel naphthalenic ligands with high affinity for the melatonin receptor
-
Yous S, Andrieux J, Howell HE, et al: Novel naphthalenic ligands with high affinity for the melatonin receptor. J Med Chem 1992; 35:1484-1486
-
(1992)
J Med Chem
, vol.35
, pp. 1484-1486
-
-
Yous, S.1
Andrieux, J.2
Howell, H.E.3
-
45
-
-
0033692454
-
Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling
-
Bogaards JJ, Hissink EM, Briggs M, et al: Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling. Eur J Pharm Sci 2000; 12:117-124
-
(2000)
Eur J Pharm Sci
, vol.12
, pp. 117-124
-
-
Bogaards, J.J.1
Hissink, E.M.2
Briggs, M.3
-
46
-
-
0027081914
-
Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression
-
Pepin MC, Pothier F, Barden N: Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol Pharmacol 1992; 42:991-995
-
(1992)
Mol Pharmacol
, vol.42
, pp. 991-995
-
-
Pepin, M.C.1
Pothier, F.2
Barden, N.3
-
47
-
-
0242575035
-
Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats
-
Chagraoui A, Protais P, Filloux T, et al: Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats. Psychopharmacology (Berl) 2003; 170:17-22
-
(2003)
Psychopharmacology (Berl)
, vol.170
, pp. 17-22
-
-
Chagraoui, A.1
Protais, P.2
Filloux, T.3
-
48
-
-
1642285042
-
Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems
-
Giorgetti M, Tecott LH: Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems. Eur J Pharmacol 2004; 488:1-9
-
(2004)
Eur J Pharmacol
, vol.488
, pp. 1-9
-
-
Giorgetti, M.1
Tecott, L.H.2
-
49
-
-
2342459611
-
Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: Involvement of melatonin and serotonin receptors
-
Bourin M, Mocaër E, Porsolt R: Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J Psychiatry Neurosci 2004; 29:126-133
-
(2004)
J Psychiatry Neurosci
, vol.29
, pp. 126-133
-
-
Bourin, M.1
Mocaër, E.2
Porsolt, R.3
-
50
-
-
0018268297
-
Behavioural despair in rats: A new model sensitive to antidepressant treatments
-
Porsolt RD, Anton G, Blavet N, et al: Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978; 47:379-391
-
(1978)
Eur J Pharmacol
, vol.47
, pp. 379-391
-
-
Porsolt, R.D.1
Anton, G.2
Blavet, N.3
-
51
-
-
23144443533
-
Antidepressant action of agomelatine (S20098) in a transgenic mouse model
-
Barden N, Shink E, Labbe M, et al: Antidepressant action of agomelatine (S20098) in a transgenic mouse model. Prog Neuropsychopharmacol Biol Psychiat 2005; 29: 08-916
-
(2005)
Prog Neuropsychopharmacol Biol Psychiat
, vol.29
, pp. 08-916
-
-
Barden, N.1
Shink, E.2
Labbe, M.3
-
52
-
-
0038050606
-
Effect of agomelatine in the chronic mild stress model of depression in the rat
-
Papp M, Gruca P, Boyer PA, et al: Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology 2003; 28:694-703
-
(2003)
Neuropsychopharmacology
, vol.28
, pp. 694-703
-
-
Papp, M.1
Gruca, P.2
Boyer, P.A.3
-
53
-
-
33646672157
-
Pharmacology of a new antidepressant: Benefit of the implication of the melatonergic system
-
Fuchs E, Simon M, Schmelting B: Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system. Int Clin Psychopharmacol 2006; 21(Suppl 1):S17-S20
-
(2006)
Int Clin Psychopharmacol
, vol.21
, Issue.SUPPL. 1
-
-
Fuchs, E.1
Simon, M.2
Schmelting, B.3
-
54
-
-
33751192681
-
Antidepressant-like effects of agomelatine (S 20098) in the learned helplessnessmodel
-
Bertaina-Anglade V, la Rochelle CD, Boyer PA, et al: Antidepressant-like effects of agomelatine (S 20098) in the learned helplessnessmodel. Behav Pharmacol 2006; 17:703-713
-
(2006)
Behav Pharmacol
, vol.17
, pp. 703-713
-
-
Bertaina-Anglade, V.1
la Rochelle, C.D.2
Boyer, P.A.3
-
55
-
-
0028916266
-
Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms
-
Redman JR, Guardiola-Lemaitre B, Brown M, et al: Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms. Psychopharmacology (Berl) 1995; 118:385-390
-
(1995)
Psychopharmacology (Berl)
, vol.118
, pp. 385-390
-
-
Redman, J.R.1
Guardiola-Lemaitre, B.2
Brown, M.3
-
56
-
-
0027362397
-
Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS)
-
Armstrong SM, McNulty OM, Guardiola-Lemaitre B, et al: Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS). Pharmacol Biochem Behav 1993; 46:45-49
-
(1993)
Pharmacol Biochem Behav
, vol.46
, pp. 45-49
-
-
Armstrong, S.M.1
McNulty, O.M.2
Guardiola-Lemaitre, B.3
-
57
-
-
0030218832
-
Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent
-
Martinet L, Guardiola-Lemaitre B, Mocaer E: Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent. Pharmacol Biochem Behav 1996; 54:713-718
-
(1996)
Pharmacol Biochem Behav
, vol.54
, pp. 713-718
-
-
Martinet, L.1
Guardiola-Lemaitre, B.2
Mocaer, E.3
-
58
-
-
0031989198
-
Entrainment of rat circadian rhythms by the melatonin agonist S-20098 requires intact suprachiasmatic nuclei but not the pineal
-
Redman JR, Francis AJ: Entrainment of rat circadian rhythms by the melatonin agonist S-20098 requires intact suprachiasmatic nuclei but not the pineal. J Biol Rhythms 1998; 13:39-51
-
(1998)
J Biol Rhythms
, vol.13
, pp. 39-51
-
-
Redman, J.R.1
Francis, A.J.2
-
59
-
-
0032834067
-
Organization of rat circadian rhythms during daily infusion of melatonin or S20098, a melatonin agonist
-
Pitrosky B, Kirsch R, Malan A, et al: Organization of rat circadian rhythms during daily infusion of melatonin or S20098, a melatonin agonist. Am J Physiol 1999; 277(3 Pt 2): R812-R828
-
(1999)
Am J Physiol
, vol.277
, Issue.3 PART 2
-
-
Pitrosky, B.1
Kirsch, R.2
Malan, A.3
-
60
-
-
0034644822
-
A melatonin agonist facilitates circadian resynchronization in old hamsters after abrupt shifts in the light-dark cycle
-
Weibel L, Turek FW, Mocaer E, et al: A melatonin agonist facilitates circadian resynchronization in old hamsters after abrupt shifts in the light-dark cycle. Brain Res 2000; 880:207-211
-
(2000)
Brain Res
, vol.880
, pp. 207-211
-
-
Weibel, L.1
Turek, F.W.2
Mocaer, E.3
-
61
-
-
24144461633
-
Phase-shifts of 24-hr rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men
-
Leproult R, Van Onderbergen A, L'hermite-Balériaux M, et al: Phase-shifts of 24-hr rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. Clin Endocrinol (Oxf) 2005; 63:298-304
-
(2005)
Clin Endocrinol (Oxf)
, vol.63
, pp. 298-304
-
-
Leproult, R.1
Van Onderbergen, A.2
L'hermite-Balériaux, M.3
-
62
-
-
16844380632
-
Social stress in tree shrews as an animal model of depression: An example of a behavioral model of a CNS disorder
-
Fuchs E: Social stress in tree shrews as an animal model of depression: an example of a behavioral model of a CNS disorder. CNS Spectr 2005; 10:182-190
-
(2005)
CNS Spectr
, vol.10
, pp. 182-190
-
-
Fuchs, E.1
-
63
-
-
33745669873
-
Effects of melatonin and agomelatine in anxiety-related procedures in rats: Interaction with diazepam
-
Loiseau F, Le Bihan C, Hamon M, et al: Effects of melatonin and agomelatine in anxiety-related procedures in rats: interaction with diazepam. Eur Neuropsychopharmacol 2006; 16:417-428
-
(2006)
Eur Neuropsychopharmacol
, vol.16
, pp. 417-428
-
-
Loiseau, F.1
Le Bihan, C.2
Hamon, M.3
-
64
-
-
84861462398
-
Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety
-
Rainer Q, Xia L, Guilloux JP, et al: Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety. Int J Neuropsychopharmacol 2011; 8:1-15
-
(2011)
Int J Neuropsychopharmacol
, vol.8
, pp. 1-15
-
-
Rainer, Q.1
Xia, L.2
Guilloux, J.P.3
-
65
-
-
2542484527
-
A comparison of GluR-A-deficient and wild-type mice on a test battery assessing sensorimotor, affective, and cognitive behaviors
-
Bannerman DM, Deacon RM, Brady S, et al: A comparison of GluR-A-deficient and wild-type mice on a test battery assessing sensorimotor, affective, and cognitive behaviors. Behav Neurosci 2004; 118:643-647
-
(2004)
Behav Neurosci
, vol.118
, pp. 643-647
-
-
Bannerman, D.M.1
Deacon, R.M.2
Brady, S.3
-
66
-
-
73549123839
-
Are the dorsal and ventral hippocampus functionally distinct structures?
-
Fanselow MS, Dong HW: Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 2010; 65:7-19
-
(2010)
Neuron
, vol.65
, pp. 7-19
-
-
Fanselow, M.S.1
Dong, H.W.2
-
67
-
-
37049039648
-
Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: Randomized, double-blind comparison with venlafaxine
-
Lemoine P, Guilleminault C, Alvarez E: Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine. J Clin Psychiatry 2007; 68: 1723-1732
-
(2007)
J Clin Psychiatry
, vol.68
, pp. 1723-1732
-
-
Lemoine, P.1
Guilleminault, C.2
Alvarez, E.3
-
68
-
-
0035377092
-
Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments
-
CANMAT Depression Work Group
-
Kennedy SH, Lam RW, Cohen NL, et al; CANMAT Depression Work Group: Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Can J Psychiatry 2001; 46(Suppl 1):38S-58S
-
(2001)
Can J Psychiatry
, vol.46
, Issue.SUPPL. 1
-
-
Kennedy, S.H.1
Lam, R.W.2
Cohen, N.L.3
-
69
-
-
0035030238
-
Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: A comparison with fluvoxamine
-
Milnacipran/Fluvoxamine Study Group
-
Clerc G; Milnacipran/Fluvoxamine Study Group: Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine. Int Clin Psychopharmacol 2001; 16:145-151
-
(2001)
Int Clin Psychopharmacol
, vol.16
, pp. 145-151
-
-
Clerc, G.1
-
70
-
-
51449112441
-
A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR
-
Kennedy SH, Rizvi S, Fulton K, et al: A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. J Clin Psychopharmacol 2008; 28:329-333
-
(2008)
J Clin Psychopharmacol
, vol.28
, pp. 329-333
-
-
Kennedy, S.H.1
Rizvi, S.2
Fulton, K.3
-
71
-
-
79955669643
-
Major depressive disorder, anhedonia and agomelatine: An openlabel study
-
Di Giannantonio M, Di Iorio G, Guglielmo R, et al: Major depressive disorder, anhedonia and agomelatine: an openlabel study. J Biol Regul Homeost Agents 2011; 25:109-114
-
(2011)
J Biol Regul Homeost Agents
, vol.25
, pp. 109-114
-
-
Di Giannantonio, M.1
Di Iorio, G.2
Guglielmo, R.3
-
72
-
-
34548446414
-
Agomelatine Bipolar Study Group: Agomelatine adjunctive therapy for acute bipolar depression: Preliminary open data
-
Calabrese JR, Guelfi JD, Perdrizet-Chevallier C: Agomelatine Bipolar Study Group: Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data. Bipolar Disord 2007; 9:628-635
-
(2007)
Bipolar Disord
, vol.9
, pp. 628-635
-
-
Calabrese, J.R.1
Guelfi, J.D.2
Perdrizet-Chevallier, C.3
-
74
-
-
78549269430
-
A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation
-
Fornaro M, Prestia D, Colicchio S, et al: A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation. Curr Neuropharmacol 2010; 8:287-304
-
(2010)
Curr Neuropharmacol
, vol.8
, pp. 287-304
-
-
Fornaro, M.1
Prestia, D.2
Colicchio, S.3
-
75
-
-
58149129754
-
Efficacy of agomelatine in generalized anxiety disorder: A randomized, double-blind, placebo-controlled study
-
Stein DJ, Ahokas AA, de Bodinat C: Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 2008; 28:561-566
-
(2008)
J Clin Psychopharmacol
, vol.28
, pp. 561-566
-
-
Stein, D.J.1
Ahokas, A.A.2
de Bodinat, C.3
-
76
-
-
80054744194
-
Possibilities of preventive treatment of migraine with the MT1-and MT2 agonist and 5-HT2c receptor antagonist agomelatin (valdoxan)
-
Tabeeva GR, Sergeev AV, Gromova SA: [Possibilities of preventive treatment of migraine with the MT1-and MT2 agonist and 5-HT2c receptor antagonist agomelatin (valdoxan)]. Zh Nevrol Psikhiatr Im S S Korsakova 2011; 111:32-36
-
(2011)
Zh Nevrol Psikhiatr Im S S Korsakova
, vol.111
, pp. 32-36
-
-
Tabeeva, G.R.1
Sergeev, A.V.2
Gromova, S.A.3
-
77
-
-
84855344910
-
Agomelatine improves sleep in patient with Fatal Familial Insomnia
-
Fibrose T, Skwik FI, Schreiner R, et al: Agomelatine improves sleep in patient with Fatal Familial Insomnia. Pharmacopsychiatry 2011; 45(1):34-36
-
(2011)
Pharmacopsychiatry
, vol.45
, Issue.1
, pp. 34-36
-
-
Fibrose, T.1
Skwik, F.I.2
Schreiner, R.3
-
78
-
-
77952115305
-
Agomelatine in the treatment of major depressive disorder: Potential for clinical effectiveness
-
Kennedy SH, Rizvi SJ: Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness. CNS Drugs 2010; 24:479-499
-
(2010)
CNS Drugs
, vol.24
, pp. 479-499
-
-
Kennedy, S.H.1
Rizvi, S.J.2
-
80
-
-
33646702013
-
Sexual function in remitted depresse patient following agomelatine
-
Kennedy SH: Sexual function in remitted depresse patient following agomelatine. Eur Neuropsychopharmacol 2005; 15 (Supp. 3):S440
-
(2005)
Eur Neuropsychopharmacol
, vol.15
, Issue.SUPPL. 3
-
-
Kennedy, S.H.1
-
81
-
-
33745795154
-
Agomelatine targets a range of major depressive disorder symptoms
-
Dubocovitch ML: Agomelatine targets a range of major depressive disorder symptoms. Curr Opin Invest drugs 2006; 7: 670-680
-
(2006)
Curr Opin Invest drugs
, vol.7
, pp. 670-680
-
-
Dubocovitch, M.L.1
-
82
-
-
42749088762
-
Activation of 5-HT2C receptors acutely induces Per1 gene expression in the rat SCN in vitro
-
Varcoe TJ, Kennaway DJ: Activation of 5-HT2C receptors acutely induces Per1 gene expression in the rat SCN in vitro. Brain Res 2008; 1209:19-28
-
(2008)
Brain Res
, vol.1209
, pp. 19-28
-
-
Varcoe, T.J.1
Kennaway, D.J.2
-
83
-
-
0032219620
-
5-HT2C receptor agonists: Pharmacological characteristics and therapeutic potential
-
Martin JR, Bös M, Jenck F, et al: 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 1998; 286:913-924
-
(1998)
J Pharmacol Exp Ther
, vol.286
, pp. 913-924
-
-
Martin, J.R.1
Bös, M.2
Jenck, F.3
-
84
-
-
35349020998
-
Limitations of current medical treatments for depression: Disturbed circadian rhythms as a possible therapeutic target
-
Lader M: Limitations of current medical treatments for depression: disturbed circadian rhythms as a possible therapeutic target. Eur Neuropsychopharmacol 2007; 17:743-755
-
(2007)
Eur Neuropsychopharmacol
, vol.17
, pp. 743-755
-
-
Lader, M.1
-
85
-
-
34948910106
-
The interaction between the internal clock and antidepressant efficacy
-
Racagni G, Riva MA, Popoli M: The interaction between the internal clock and antidepressant efficacy. Int Clin Psychopharmacol 2007; 22(Suppl 2):S9-S14
-
(2007)
Int Clin Psychopharmacol
, vol.22
, Issue.SUPPL. 2
-
-
Racagni, G.1
Riva, M.A.2
Popoli, M.3
-
86
-
-
77950884687
-
Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients
-
Quera-Salva MA, Lemoine P, Guilleminault C: Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients. Hum Psychopharmacol 2010; 25:222-229
-
(2010)
Hum Psychopharmacol
, vol.25
, pp. 222-229
-
-
Quera-Salva, M.A.1
Lemoine, P.2
Guilleminault, C.3
-
87
-
-
34147173300
-
Circadian genes, rhythms and the biology of mood disorders
-
McClung CA: Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther 2007; 114:222-232
-
(2007)
Pharmacol Ther
, vol.114
, pp. 222-232
-
-
McClung, C.A.1
-
88
-
-
34249883579
-
Challenging the omnipotence of the suprachiasmatic timekeeper: Are circadian oscillators present throughout the mammalian brain?
-
Guilding C, Piggins HD: Challenging the omnipotence of the suprachiasmatic timekeeper: are circadian oscillators present throughout the mammalian brain? Eur J Neurosci 2007; 25:3195-3216
-
(2007)
Eur J Neurosci
, vol.25
, pp. 3195-3216
-
-
Guilding, C.1
Piggins, H.D.2
-
89
-
-
0033603542
-
Stability, precision, and near-24-hour period of the human circadian pacemaker
-
Czeisler CA, Duffy JF, Shanahan TL, et al: Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999; 284:2177-2181
-
(1999)
Science
, vol.284
, pp. 2177-2181
-
-
Czeisler, C.A.1
Duffy, J.F.2
Shanahan, T.L.3
-
90
-
-
0018762961
-
Neural regulation of circadian rhythms
-
Rusak B, Zucker I: Neural regulation of circadian rhythms. Physiol Rev 1979; 59:449-526
-
(1979)
Physiol Rev
, vol.59
, pp. 449-526
-
-
Rusak, B.1
Zucker, I.2
-
91
-
-
33846571948
-
Altered sleep/wake patterns and mental performance
-
Akerstedt T: Altered sleep/wake patterns and mental performance. Physiol Behav 2007; 90:209-218
-
(2007)
Physiol Behav
, vol.90
, pp. 209-218
-
-
Akerstedt, T.1
-
92
-
-
0029923655
-
Circadian rhythm adjustment: Difficulties in assessment caused by masking
-
Waterhouse J, Minors D, Akerstedt T, et al: Circadian rhythm adjustment: difficulties in assessment caused by masking. Pathol Biol (Paris) 1996; 44:205-207
-
(1996)
Pathol Biol (Paris)
, vol.44
, pp. 205-207
-
-
Waterhouse, J.1
Minors, D.2
Akerstedt, T.3
-
93
-
-
0030761518
-
Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock
-
Liu C, Weaver DR, Jin X, et al: Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997; 19:91-102
-
(1997)
Neuron
, vol.19
, pp. 91-102
-
-
Liu, C.1
Weaver, D.R.2
Jin, X.3
-
94
-
-
0037304598
-
Targeted disruption of the mouse Mel(1b) melatonin receptor
-
Jin X, von Gall C, Pieschl RL, et al: Targeted disruption of the mouse Mel(1b) melatonin receptor. Mol Cell Biol 2003; 23:1054-1060
-
(2003)
Mol Cell Biol
, vol.23
, pp. 1054-1060
-
-
Jin, X.1
von Gall, C.2
Pieschl, R.L.3
-
95
-
-
59549093363
-
Pathophysiology of depression: Role of sleep and the melatonergic system
-
Srinivasan V, Pandi-Perumal SR, Trakht I, et al: Pathophysiology of depression: role of sleep and the melatonergic system. Psychiatry Res 2009; 165:201-214
-
(2009)
Psychiatry Res
, vol.165
, pp. 201-214
-
-
Srinivasan, V.1
Pandi-Perumal, S.R.2
Trakht, I.3
-
96
-
-
34948858413
-
Evidence of agomelatine's antidepressant efficacy: The key points
-
Eser D, Baghai TC, Möller HJ: Evidence of agomelatine's antidepressant efficacy: the key points. Int Clin Psychopharmacol 2007; 22(Suppl 2):S15-S19
-
(2007)
Int Clin Psychopharmacol
, vol.22
, Issue.SUPPL. 2
-
-
Eser, D.1
Baghai, T.C.2
Möller, H.J.3
-
97
-
-
79954633976
-
The emerging role of melatonin agonists in the treatment of major depression: Focus on agomelatine
-
De Berardis D, Di Iorio G, Acciavatti T, et al: The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine. CNS Neurol Disord Drug Targets 2011; 10:119-132
-
(2011)
CNS Neurol Disord Drug Targets
, vol.10
, pp. 119-132
-
-
De Berardis, D.1
Di Iorio, G.2
Acciavatti, T.3
-
98
-
-
78049520183
-
The antidepressant agomelatine improves the quality of life of depressed patients: Implications for remission
-
Llorca PM: The antidepressant agomelatine improves the quality of life of depressed patients: implications for remission. J Psychopharmacol 2010; 24(Suppl):21-26
-
(2010)
J Psychopharmacol
, vol.24
, Issue.SUPPL.
, pp. 21-26
-
-
Llorca, P.M.1
-
100
-
-
79960313397
-
Strategies to achieve clinical effectiveness: Refining existing therapies and pursuing emerging targets
-
Kennedy SH, Young AH, Blier P: Strategies to achieve clinical effectiveness: refining existing therapies and pursuing emerging targets. J Affect Disord 2011; 132(Suppl 1):S21-S28
-
(2011)
J Affect Disord
, vol.132
, Issue.SUPPL. 1
-
-
Kennedy, S.H.1
Young, A.H.2
Blier, P.3
-
101
-
-
69949159287
-
Emerging drugs for major depressive disorder
-
Kennedy SH, Rizvi SJ: Emerging drugs for major depressive disorder. Expert Opin Emerg Drugs 2009; 14:439-453
-
(2009)
Expert Opin Emerg Drugs
, vol.14
, pp. 439-453
-
-
Kennedy, S.H.1
Rizvi, S.J.2
-
102
-
-
77955172537
-
Agomelatine, the first melatonergic antidepressant: Discovery, characterization and development
-
de Bodinat C, Guardiola-Lemaitre B, Mocaër E, et al: Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov 2010; 9:628-642
-
(2010)
Nat Rev Drug Discov
, vol.9
, pp. 628-642
-
-
de Bodinat, C.1
Guardiola-Lemaitre, B.2
Mocaër, E.3
-
103
-
-
33744919791
-
Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis
-
Banasr M, Soumier A, Hery M, et al: Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biol Psychiatry 2006; 59:1087-1096
-
(2006)
Biol Psychiatry
, vol.59
, pp. 1087-1096
-
-
Banasr, M.1
Soumier, A.2
Hery, M.3
-
104
-
-
70349142643
-
Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus
-
Soumier A, Banasr M, Lortet S, et al: Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus. Neuropsychopharmacology 2009; 34:2390-2403
-
(2009)
Neuropsychopharmacology
, vol.34
, pp. 2390-2403
-
-
Soumier, A.1
Banasr, M.2
Lortet, S.3
-
105
-
-
77957144923
-
Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptorimpaired mice
-
Païzanis E, Renoir T, Lelievre V, et al: Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptorimpaired mice. Int J Neuropsychopharmacol 2010; 13:759-774
-
(2010)
Int J Neuropsychopharmacol
, vol.13
, pp. 759-774
-
-
Païzanis, E.1
Renoir, T.2
Lelievre, V.3
-
106
-
-
0032434817
-
Functional differentiation in the hippocampus
-
Moser MB, Moser EI: Functional differentiation in the hippocampus. Hippocampus 1998; 8:608-619
-
(1998)
Hippocampus
, vol.8
, pp. 608-619
-
-
Moser, M.B.1
Moser, E.I.2
-
107
-
-
38949158786
-
Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells
-
Wang JW, David DJ, Monckton JE, et al: Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J Neurosci 2008; 28:1374-1384
-
(2008)
J Neurosci
, vol.28
, pp. 1374-1384
-
-
Wang, J.W.1
David, D.J.2
Monckton, J.E.3
-
108
-
-
34548402661
-
The role of hippocampus in anxiety: Intracerebral infusion studies
-
Engin E, Treit D: The role of hippocampus in anxiety: intracerebral infusion studies. Behav Pharmacol 2007; 18:365-374
-
(2007)
Behav Pharmacol
, vol.18
, pp. 365-374
-
-
Engin, E.1
Treit, D.2
-
109
-
-
77649107286
-
Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: A randomized, double-blind comparison with sertraline
-
Kasper S, Hajak G, Wulff K, et al: Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J Clin Psychiatry 2010; 71:109-120
-
(2010)
J Clin Psychiatry
, vol.71
, pp. 109-120
-
-
Kasper, S.1
Hajak, G.2
Wulff, K.3
-
110
-
-
36048935395
-
Protective effect of St. John's wort (Hypericum perforatum) extract on 72-hour sleep deprivation-induced anxiety-like behavior and oxidative damage in mice
-
Kumar A, Singh A: Protective effect of St. John's wort (Hypericum perforatum) extract on 72-hour sleep deprivation-induced anxiety-like behavior and oxidative damage in mice. Planta Med 2007; 73:1358-1364
-
(2007)
Planta Med
, vol.73
, pp. 1358-1364
-
-
Kumar, A.1
Singh, A.2
-
111
-
-
4644260713
-
Uncoupling proteins and sleep deprivation
-
Cirelli C, Tononi G: Uncoupling proteins and sleep deprivation. Arch Ital Biol 2004; 142:541-549
-
(2004)
Arch Ital Biol
, vol.142
, pp. 541-549
-
-
Cirelli, C.1
Tononi, G.2
-
112
-
-
33746922371
-
Changes in brain gene expression after long-term sleep deprivation
-
Cirelli C, Faraguna U, Tononi G: Changes in brain gene expression after long-term sleep deprivation. J Neurochem 2006; 98:1632-1645
-
(2006)
J Neurochem
, vol.98
, pp. 1632-1645
-
-
Cirelli, C.1
Faraguna, U.2
Tononi, G.3
-
113
-
-
39749149696
-
Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression
-
Szuster-Ciesielska A, Sotwinska M, Stachura A, et al: Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:686-694
-
(2008)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.32
, pp. 686-694
-
-
Szuster-Ciesielska, A.1
Sotwinska, M.2
Stachura, A.3
-
114
-
-
77950575478
-
Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder
-
Andreazza AC, Shao L, Wang JF, et al: Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 2010; 67:360-368
-
(2010)
Arch Gen Psychiatry
, vol.67
, pp. 360-368
-
-
Andreazza, A.C.1
Shao, L.2
Wang, J.F.3
-
115
-
-
79959611025
-
Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression
-
Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, et al: Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 2011; 16:751-762
-
(2011)
Mol Psychiatry
, vol.16
, pp. 751-762
-
-
Shelton, R.C.1
Claiborne, J.2
Sidoryk-Wegrzynowicz, M.3
-
116
-
-
79954599845
-
Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients
-
Maes M, Ruckoanich P, Chang YS, et al: Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:769-783
-
(2011)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.35
, pp. 769-783
-
-
Maes, M.1
Ruckoanich, P.2
Chang, Y.S.3
-
117
-
-
77956549615
-
Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness
-
Che Y, Wang JF, Shao L, et al: Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J Psychiatry Neurosci 2010; 35:296-302
-
(2010)
J Psychiatry Neurosci
, vol.35
, pp. 296-302
-
-
Che, Y.1
Wang, J.F.2
Shao, L.3
-
118
-
-
77957724723
-
Increased glycogen synthase kinase-3b mRNA level in the hippocampus of patients with major depression: A study using the stanley neuropathology consortium integrative database
-
Oh DH, Park YC, Kim SH: Increased glycogen synthase kinase-3b mRNA level in the hippocampus of patients with major depression: a study using the stanley neuropathology consortium integrative database. Psychiatry Investig 2010; 7:202-207
-
(2010)
Psychiatry Investig
, vol.7
, pp. 202-207
-
-
Oh, D.H.1
Park, Y.C.2
Kim, S.H.3
-
119
-
-
51349085199
-
Oxidative stress markers in bipolar disorder: A meta-analysis
-
Andreazza AC, Kauer-Sant'anna M, Frey BN, et al: Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 2008; 111:135-144
-
(2008)
J Affect Disord
, vol.111
, pp. 135-144
-
-
Andreazza, A.C.1
Kauer-Sant'anna, M.2
Frey, B.N.3
-
120
-
-
51349132292
-
Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia
-
Kunz M, Gama CS, Andreazza AC, et al: Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:1677-1681
-
(2008)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.32
, pp. 1677-1681
-
-
Kunz, M.1
Gama, C.S.2
Andreazza, A.C.3
-
121
-
-
67749122382
-
Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia
-
Wang JF, Shao L, Sun X, et al: Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord 2009; 11:523-529
-
(2009)
Bipolar Disord
, vol.11
, pp. 523-529
-
-
Wang, J.F.1
Shao, L.2
Sun, X.3
-
122
-
-
79952959359
-
Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia
-
Clay HB, Sillivan S, Konradi C: Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 2011; 29:311-324
-
(2011)
Int J Dev Neurosci
, vol.29
, pp. 311-324
-
-
Clay, H.B.1
Sillivan, S.2
Konradi, C.3
-
123
-
-
79851513447
-
Prolidase activity and its diagnostic performance in bipolar disorder
-
Selek S, Altindag A, Saracoglu G, et al: Prolidase activity and its diagnostic performance in bipolar disorder. J Affect Disord 2011; 129:84-86
-
(2011)
J Affect Disord
, vol.129
, pp. 84-86
-
-
Selek, S.1
Altindag, A.2
Saracoglu, G.3
-
124
-
-
79952898791
-
Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance
-
Ross BM, Maxwell R, Glen I: Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:446-453
-
(2011)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.35
, pp. 446-453
-
-
Ross, B.M.1
Maxwell, R.2
Glen, I.3
-
125
-
-
80052961123
-
Morphometric post-mortem studies in bipolar disorder: Possible association with oxidative stress and apoptosis
-
Gigante AD, Young LT, Yatham LN, et al: Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int J Neuropsychopharmacol 2011; 14:1075-1089
-
(2011)
Int J Neuropsychopharmacol
, vol.14
, pp. 1075-1089
-
-
Gigante, A.D.1
Young, L.T.2
Yatham, L.N.3
-
126
-
-
4644342481
-
Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment
-
Atmaca M, Tezcan E, Kuloglu M, et al: Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. Eur Arch Psychiatry Clin Neurosci 2004; 254:231-235
-
(2004)
Eur Arch Psychiatry Clin Neurosci
, vol.254
, pp. 231-235
-
-
Atmaca, M.1
Tezcan, E.2
Kuloglu, M.3
-
127
-
-
28444445972
-
Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice
-
Hovatta I, Tennant RS, Helton R, et al: Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 2005; 438:662-666
-
(2005)
Nature
, vol.438
, pp. 662-666
-
-
Hovatta, I.1
Tennant, R.S.2
Helton, R.3
-
128
-
-
47749091233
-
The impact of high anxiety level on the oxidative status of mouse peripheral blood lymphocytes, granulocytes, and monocytes
-
Rammal H, Bouayed J, Younos C, et al: The impact of high anxiety level on the oxidative status of mouse peripheral blood lymphocytes, granulocytes, and monocytes. Eur J Pharmacol 2008; 589:173-175
-
(2008)
Eur J Pharmacol
, vol.589
, pp. 173-175
-
-
Rammal, H.1
Bouayed, J.2
Younos, C.3
-
129
-
-
1642564368
-
Ethanolamine and phosphoethanolamine inhibit mitochondrial function in vitro: Implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder
-
Modica-Napolitano JS, Renshaw PF: Ethanolamine and phosphoethanolamine inhibit mitochondrial function in vitro: implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder. Biol Psychiatry 2004; 55:273-277
-
(2004)
Biol Psychiatry
, vol.55
, pp. 273-277
-
-
Modica-Napolitano, J.S.1
Renshaw, P.F.2
-
130
-
-
34447132960
-
Psychiatric comorbidity in 36 adults with mitochondrial cytopathies
-
Fattal O, Link J, Quinn K, et al: Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectr 2007; 12:429-438
-
(2007)
CNS Spectr
, vol.12
, pp. 429-438
-
-
Fattal, O.1
Link, J.2
Quinn, K.3
-
131
-
-
79954578338
-
Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders
-
Gardner A, Boles RG: Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:730-743
-
(2011)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.35
, pp. 730-743
-
-
Gardner, A.1
Boles, R.G.2
-
132
-
-
81955161265
-
Mitochondria, oligodendrocytes, and inflammation in bipolar disorder: Evidence from transcriptome studies points to intriguing parallels with multiple sclerosis
-
Konradi C, Sillivan SE, Clay HB: Mitochondria, oligodendrocytes, and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis 2012; 45(1):37-47
-
(2012)
Neurobiol Dis
, vol.45
, Issue.1
, pp. 37-47
-
-
Konradi, C.1
Sillivan, S.E.2
Clay, H.B.3
-
133
-
-
8244248453
-
Plasma levels of cyclic GMP, immune parameters and depressive status during interferon therapy. A prospective study in Japan
-
Kagaya A, Uchitomi Y, Takezaki E, et al: Plasma levels of cyclic GMP, immune parameters and depressive status during interferon therapy. A prospective study in Japan. Neuropsychobiology 1997; 35:128-131
-
(1997)
Neuropsychobiology
, vol.35
, pp. 128-131
-
-
Kagaya, A.1
Uchitomi, Y.2
Takezaki, E.3
-
134
-
-
79954613032
-
Cytokines-mediated inflammation and decreased neurogenesis in animal models of depression
-
Song C, Wang H: Cytokines-mediated inflammation and decreased neurogenesis in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:760-768
-
(2011)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.35
, pp. 760-768
-
-
Song, C.1
Wang, H.2
-
135
-
-
79959928927
-
Antidepressants and neuroinflammation: Can antidepressants calm glial rage down?
-
Hashioka S: Antidepressants and neuroinflammation: can antidepressants calm glial rage down? Mini Rev Med Chem 2011; 11:555-564
-
(2011)
Mini Rev Med Chem
, vol.11
, pp. 555-564
-
-
Hashioka, S.1
-
136
-
-
77950022786
-
Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients
-
Rao JS, Harry GJ, Rapoport SI, et al: Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 2010; 15:384-392
-
(2010)
Mol Psychiatry
, vol.15
, pp. 384-392
-
-
Rao, J.S.1
Harry, G.J.2
Rapoport, S.I.3
-
137
-
-
75949107129
-
Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients
-
Kim HW, Rapoport SI, Rao JS: Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis 2010; 37:596-603
-
(2010)
Neurobiol Dis
, vol.37
, pp. 596-603
-
-
Kim, H.W.1
Rapoport, S.I.2
Rao, J.S.3
-
138
-
-
76749098860
-
Brain arachidonic acid uptake and turnover: Implications for signaling and bipolar disorder
-
Duncan RE, Bazinet RP: Brain arachidonic acid uptake and turnover: implications for signaling and bipolar disorder. Curr Opin Clin Nutr Metab Care 2010; 13:130-138
-
(2010)
Curr Opin Clin Nutr Metab Care
, vol.13
, pp. 130-138
-
-
Duncan, R.E.1
Bazinet, R.P.2
-
139
-
-
0035037342
-
Localization of the melatonin-related receptor in the rodent brain and peripheral tissues
-
Drew JE, Barrett P, Mercer JG, et al: Localization of the melatonin-related receptor in the rodent brain and peripheral tissues. J Neuroendocrinol 2001; 13:453-458
-
(2001)
J Neuroendocrinol
, vol.13
, pp. 453-458
-
-
Drew, J.E.1
Barrett, P.2
Mercer, J.G.3
-
140
-
-
0028155097
-
Melatonin receptor distribution in the brain and retina of a lizard, Anolis carolinensis
-
Wiechmann AF, Wirsig-Wiechmann CR: Melatonin receptor distribution in the brain and retina of a lizard, Anolis carolinensis. Brain Behav Evol 1994; 43:26-33
-
(1994)
Brain Behav Evol
, vol.43
, pp. 26-33
-
-
Wiechmann, A.F.1
Wirsig-Wiechmann, C.R.2
-
141
-
-
0026066725
-
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding
-
Stankov B, Cozzi B, Lucini V, et al: Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding. Neurosci Lett 1991; 133:68-72
-
(1991)
Neurosci Lett
, vol.133
, pp. 68-72
-
-
Stankov, B.1
Cozzi, B.2
Lucini, V.3
-
142
-
-
0032556682
-
Melatonin receptor subtype expression in human cerebellum
-
Al-Ghoul WM, Herman MD, Dubocovich ML: Melatonin receptor subtype expression in human cerebellum. Neuroreport 1998; 9:4063-4068
-
(1998)
Neuroreport
, vol.9
, pp. 4063-4068
-
-
Al-Ghoul, W.M.1
Herman, M.D.2
Dubocovich, M.L.3
-
143
-
-
12344268788
-
Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease
-
Savaskan E, Ayoub MA, Ravid R, et al: Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. J Pineal Res 2005; 38:10-16
-
(2005)
J Pineal Res
, vol.38
, pp. 10-16
-
-
Savaskan, E.1
Ayoub, M.A.2
Ravid, R.3
-
144
-
-
49549085247
-
Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress
-
Das A, Belagodu A, Reiter RJ, et al: Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress. J Pineal Res 2008; 45:117-124
-
(2008)
J Pineal Res
, vol.45
, pp. 117-124
-
-
Das, A.1
Belagodu, A.2
Reiter, R.J.3
-
145
-
-
51649122290
-
Favorable effects of a prolonged treatment with melatonin on the level of oxidative damage and neurodegeneration in senescenceaccelerated mice
-
Caballero B, Vega-Naredo I, Sierra V, et al: Favorable effects of a prolonged treatment with melatonin on the level of oxidative damage and neurodegeneration in senescenceaccelerated mice. J Pineal Res 2008; 45:302-311
-
(2008)
J Pineal Res
, vol.45
, pp. 302-311
-
-
Caballero, B.1
Vega-Naredo, I.2
Sierra, V.3
-
146
-
-
75149124310
-
The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors
-
Das A, McDowell M, Pava MJ, et al: The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors. J Pineal Res 2010; 48:157-169
-
(2010)
J Pineal Res
, vol.48
, pp. 157-169
-
-
Das, A.1
McDowell, M.2
Pava, M.J.3
-
147
-
-
79960383133
-
Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors
-
Choi SI, Dadakhujaev S, Ryu H, et al: Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors. J Pineal Res 2011; 51:94-103
-
(2011)
J Pineal Res
, vol.51
, pp. 94-103
-
-
Choi, S.I.1
Dadakhujaev, S.2
Ryu, H.3
-
148
-
-
79954631683
-
Nitric oxide and major depression
-
Dhir A, Kulkarni SK: Nitric oxide and major depression. Nitric Oxide 2011; 24:125-131
-
(2011)
Nitric Oxide
, vol.24
, pp. 125-131
-
-
Dhir, A.1
Kulkarni, S.K.2
-
149
-
-
39649109917
-
The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode
-
Selek S, Savas HA, Gergerlioglu HS, et al: The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord 2008; 107:89-94
-
(2008)
J Affect Disord
, vol.107
, pp. 89-94
-
-
Selek, S.1
Savas, H.A.2
Gergerlioglu, H.S.3
-
150
-
-
0036720341
-
Melatonin reduces nonadrenergic, non-cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro
-
Storr M, Koppitz P, Sibaev A, et al: Melatonin reduces nonadrenergic, non-cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro. J Pineal Res 2002; 33: 101-108
-
(2002)
J Pineal Res
, vol.33
, pp. 101-108
-
-
Storr, M.1
Koppitz, P.2
Sibaev, A.3
-
151
-
-
77949746666
-
The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity
-
Castrén E, Rantamäki T: The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol 2010; 70:289-297
-
(2010)
Dev Neurobiol
, vol.70
, pp. 289-297
-
-
Castrén, E.1
Rantamäki, T.2
-
152
-
-
77955078119
-
Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions
-
Hashimoto K: Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin Neurosci 2010; 64:341-357
-
(2010)
Psychiatry Clin Neurosci
, vol.64
, pp. 341-357
-
-
Hashimoto, K.1
-
153
-
-
78651076464
-
The role of BDNF in depression on the basis of its location in the neural circuitry
-
Yu H, Chen ZY: The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol Sin 2011; 32:3-11
-
(2011)
Acta Pharmacol Sin
, vol.32
, pp. 3-11
-
-
Yu, H.1
Chen, Z.Y.2
-
154
-
-
79551638797
-
The role of BDNF as a mediator of neuroplasticity in bipolar disorder
-
Grande I, Fries GR, Kunz M, et al: The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig 2010; 7:243-250
-
(2010)
Psychiatry Investig
, vol.7
, pp. 243-250
-
-
Grande, I.1
Fries, G.R.2
Kunz, M.3
-
155
-
-
79958747390
-
Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis
-
Fernandes BS, Gama CS, Ceresér KM, et al: Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 2011; 45:995-1004
-
(2011)
J Psychiatr Res
, vol.45
, pp. 995-1004
-
-
Fernandes, B.S.1
Gama, C.S.2
Ceresér, K.M.3
-
156
-
-
44649165647
-
Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells
-
Imbesi M, Uz T, Dzitoyeva S, et al: Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells. Neurosci Lett 2008; 439:34-36
-
(2008)
Neurosci Lett
, vol.439
, pp. 34-36
-
-
Imbesi, M.1
Uz, T.2
Dzitoyeva, S.3
-
157
-
-
77649107717
-
Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration
-
Molteni R, Calabrese F, Pisoni S, et al: Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration. World J Biol Psychiatry 2010; 11:148-153
-
(2010)
World J Biol Psychiatry
, vol.11
, pp. 148-153
-
-
Molteni, R.1
Calabrese, F.2
Pisoni, S.3
-
158
-
-
0036720357
-
Receptor (MT(1) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1
-
Peschke E, Mühlbauer E, Musshoff U, et al: Receptor (MT(1) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1. J Pineal Res 2002; 33:63-71
-
(2002)
J Pineal Res
, vol.33
, pp. 63-71
-
-
Peschke, E.1
Mühlbauer, E.2
Musshoff, U.3
-
159
-
-
0019782129
-
Subsensitivity of human beta-adrenergic adenylate cyclase after salbutamol treatment of depression
-
Lerer B, Ebstein RP, Belmaker RH: Subsensitivity of human beta-adrenergic adenylate cyclase after salbutamol treatment of depression. Psychopharmacology (Berl) 1981; 75:169-172
-
(1981)
Psychopharmacology (Berl)
, vol.75
, pp. 169-172
-
-
Lerer, B.1
Ebstein, R.P.2
Belmaker, R.H.3
-
160
-
-
62149117324
-
Chronic imipramine downregulates cyclic AMP signaling in rat hippocampus
-
Reierson GW, Mastronardi CA, Licinio J, et al: Chronic imipramine downregulates cyclic AMP signaling in rat hippocampus. Neuroreport 2009; 20:307-311
-
(2009)
Neuroreport
, vol.20
, pp. 307-311
-
-
Reierson, G.W.1
Mastronardi, C.A.2
Licinio, J.3
-
161
-
-
28844473025
-
Novel targets for valproic acid: Up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells
-
Castro LM, Gallant M, Niles LP: Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. J Neurochem 2005; 95:1227-1236
-
(2005)
J Neurochem
, vol.95
, pp. 1227-1236
-
-
Castro, L.M.1
Gallant, M.2
Niles, L.P.3
-
162
-
-
43049123138
-
Melatonin regulates the viability and differentiation of rat midbrain neural stem cells
-
Kong X, Li X, Cai Z, et al: Melatonin regulates the viability and differentiation of rat midbrain neural stem cells. Cell Mol Neurobiol 2008; 28:569-579
-
(2008)
Cell Mol Neurobiol
, vol.28
, pp. 569-579
-
-
Kong, X.1
Li, X.2
Cai, Z.3
-
163
-
-
51449102968
-
Altered glial cell linederived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: A comparative post-mortem study
-
Michel TM, Frangou S, Camara S, et al: Altered glial cell linederived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study. Eur Psychiatry 2008; 23:413-420
-
(2008)
Eur Psychiatry
, vol.23
, pp. 413-420
-
-
Michel, T.M.1
Frangou, S.2
Camara, S.3
-
164
-
-
79960291275
-
Association study between plasma GDNF and cognitive function in late-onset depression
-
Wang X, Hou Z, Yuan Y, et al: Association study between plasma GDNF and cognitive function in late-onset depression. J Affect Disord 2011; 132:418-421
-
(2011)
J Affect Disord
, vol.132
, pp. 418-421
-
-
Wang, X.1
Hou, Z.2
Yuan, Y.3
-
165
-
-
80054115722
-
Ndesalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells:A putative cellularmechanism for quetiapine as antidepressant
-
Di Benedetto B, Kühn R, Nothdurfter C, et al: Ndesalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells:A putative cellularmechanism for quetiapine as antidepressant. Neuropharmacology 2012; 62(1):209-216
-
(2012)
Neuropharmacology
, vol.62
, Issue.1
, pp. 209-216
-
-
Di Benedetto, B.1
Kühn, R.2
Nothdurfter, C.3
-
166
-
-
12944335008
-
Neural stem cells express melatonin receptors and neurotrophic factors: Colocalization of the MT1 receptor with neuronal and glial markers
-
Niles LP, Armstrong KJ, Rincón Castro LM, et al: Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers. BMC Neurosci 2004; 5:41
-
(2004)
BMC Neurosci
, vol.5
, pp. 41
-
-
Niles, L.P.1
Armstrong, K.J.2
Rincón Castro, L.M.3
-
167
-
-
0020986403
-
Dopamine and depression: A review of recent evidence. I. Empirical studies
-
Willner P: Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain Res 1983; 287:211-224
-
(1983)
Brain Res
, vol.287
, pp. 211-224
-
-
Willner, P.1
-
168
-
-
9444286419
-
Dopamine, depression and antidepressants
-
Dailly E, Chenu F, Renard CE, et al: Dopamine, depression and antidepressants. Fundam Clin Pharmacol 2004; 18:601-607
-
(2004)
Fundam Clin Pharmacol
, vol.18
, pp. 601-607
-
-
Dailly, E.1
Chenu, F.2
Renard, C.E.3
-
169
-
-
33746900423
-
The mesolimbic dopamine reward circuit in depression
-
Nestler EJ, Carlezon WA Jr: The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006; 59:1151-1159
-
(2006)
Biol Psychiatry
, vol.59
, pp. 1151-1159
-
-
Nestler, E.J.1
Carlezon Jr., W.A.2
-
170
-
-
0034756697
-
Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls
-
Neumeister A, Willeit M, Praschak-Rieder N, et al: Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychol Med 2001; 31:1467-1473
-
(2001)
Psychol Med
, vol.31
, pp. 1467-1473
-
-
Neumeister, A.1
Willeit, M.2
Praschak-Rieder, N.3
-
171
-
-
0029835266
-
Dopamine and circadian rhythms in seasonal affective disorder
-
Partonen T: Dopamine and circadian rhythms in seasonal affective disorder. Med Hypotheses 1996; 47:191-192
-
(1996)
Med Hypotheses
, vol.47
, pp. 191-192
-
-
Partonen, T.1
-
172
-
-
57149127712
-
The melatonin receptor MT1 is required for the differential regulatory actions of melatonin on neuronal 'clock' gene expression in striatal neurons in vitro
-
Imbesi M, Arslan AD, Yildiz S, et al: The melatonin receptor MT1 is required for the differential regulatory actions of melatonin on neuronal 'clock' gene expression in striatal neurons in vitro. J Pineal Res 2009; 46:87-94
-
(2009)
J Pineal Res
, vol.46
, pp. 87-94
-
-
Imbesi, M.1
Arslan, A.D.2
Yildiz, S.3
-
173
-
-
77956263606
-
Altered expression of circadian rhythm genes among individuals with a history of depression
-
Gouin JP, Connors J, Kiecolt-Glaser JK, et al: Altered expression of circadian rhythm genes among individuals with a history of depression. J Affect Disord 2010; 126:161-166
-
(2010)
J Affect Disord
, vol.126
, pp. 161-166
-
-
Gouin, J.P.1
Connors, J.2
Kiecolt-Glaser, J.K.3
-
174
-
-
77951113131
-
Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder
-
Soria V, Martínez-Amorós E, Escaramís G, et al: Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology 2010; 35:1279-1289
-
(2010)
Neuropsychopharmacology
, vol.35
, pp. 1279-1289
-
-
Soria, V.1
Martínez-Amorós, E.2
Escaramís, G.3
-
175
-
-
34447546856
-
Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression
-
Benedetti F, Dallaspezia S, Fulgosi MC, et al: Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression. Am J Med Genet B Neuropsychiatr Genet 2007; 144B:631-635
-
(2007)
Am J Med Genet B Neuropsychiatr Genet
, vol.144 B
, pp. 631-635
-
-
Benedetti, F.1
Dallaspezia, S.2
Fulgosi, M.C.3
-
176
-
-
0142188193
-
Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression
-
Benedetti F, Serretti A, Colombo C, et al: Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet B Neuropsychiatr Genet 2003; 123B:23-26
-
(2003)
Am J Med Genet B Neuropsychiatr Genet
, vol.123 B
, pp. 23-26
-
-
Benedetti, F.1
Serretti, A.2
Colombo, C.3
-
177
-
-
34247634564
-
Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression
-
Partonen T, Treutlein J, Alpman A, et al: Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann Med 2007; 39:229-238
-
(2007)
Ann Med
, vol.39
, pp. 229-238
-
-
Partonen, T.1
Treutlein, J.2
Alpman, A.3
-
178
-
-
0038727151
-
Circadian clockrelated polymorphisms in seasonal affective disorder and their relevance to diurnal preference
-
Johansson C, Willeit M, Smedh C, et al: Circadian clockrelated polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 2003; 28:734-739
-
(2003)
Neuropsychopharmacology
, vol.28
, pp. 734-739
-
-
Johansson, C.1
Willeit, M.2
Smedh, C.3
-
179
-
-
78650800876
-
MT2 receptors mediate the inhibitory effects of melatonin on nitric oxideinduced relaxation of porcine isolated coronary arteries
-
Tunstall RR, Shukla P, Grazul-Bilska A, et al: MT2 receptors mediate the inhibitory effects of melatonin on nitric oxideinduced relaxation of porcine isolated coronary arteries. J Pharmacol Exp Ther 2011; 336:127-133
-
(2011)
J Pharmacol Exp Ther
, vol.336
, pp. 127-133
-
-
Tunstall, R.R.1
Shukla, P.2
Grazul-Bilska, A.3
-
180
-
-
0242269986
-
Melatonin prevents apoptosis and enhances HSP27 mRNA expression induced by heat shock in HL-60 cells: Possible involvement of the MT2 receptor
-
Cabrera J, Quintana J, Reiter RJ, et al: Melatonin prevents apoptosis and enhances HSP27 mRNA expression induced by heat shock in HL-60 cells: possible involvement of the MT2 receptor. J Pineal Res 2003; 35:231-238
-
(2003)
J Pineal Res
, vol.35
, pp. 231-238
-
-
Cabrera, J.1
Quintana, J.2
Reiter, R.J.3
-
181
-
-
34249009631
-
Signs of apoptosis of immunocompetent cells in patients with depression
-
Ivanova SA, Semke VY, Vetlugina TP, et al: Signs of apoptosis of immunocompetent cells in patients with depression. Neurosci Behav Physiol 2007; 37:527-530
-
(2007)
Neurosci Behav Physiol
, vol.37
, pp. 527-530
-
-
Ivanova, S.A.1
Semke, V.Y.2
Vetlugina, T.P.3
-
182
-
-
67650470151
-
"Killing the Blues": A role for cellular suicide (apoptosis) in depression and the antidepressant response?
-
McKernan DP, Dinan TG, Cryan JF: "Killing the Blues": a role for cellular suicide (apoptosis) in depression and the antidepressant response? Prog Neurobiol 2009; 88:246-263
-
(2009)
Prog Neurobiol
, vol.88
, pp. 246-263
-
-
McKernan, D.P.1
Dinan, T.G.2
Cryan, J.F.3
-
183
-
-
84856693660
-
Extrapineal melatonin: Analysis of its subcellular distribution and daily fluctuations
-
Venegas C, García JA, Escames G, et al: Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res 2011; 52:217-227
-
(2011)
J Pineal Res
, vol.52
, pp. 217-227
-
-
Venegas, C.1
García, J.A.2
Escames, G.3
-
184
-
-
80052849856
-
Agomelatine: A narrative review
-
Demyttenaere K: Agomelatine: a narrative review. Eur Neuropsychopharmacol 2011; 21(Suppl 4):S703-S709
-
(2011)
Eur Neuropsychopharmacol
, vol.21
, Issue.SUPPL. 4
-
-
Demyttenaere, K.1
-
186
-
-
34948841405
-
Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder
-
Olié JP, Kasper S: Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol 2007; 10(5): 661-673
-
(2007)
Int J Neuropsychopharmacol
, vol.10
, Issue.5
, pp. 661-673
-
-
Olié, J.P.1
Kasper, S.2
|